Mayne Pharma (ASX:MYX) Receives Court Approval for Acquisition Scheme
Mayne Pharma (ASX:MYX) receives Supreme Court approval for Cosette Pharmaceuticals’ acquisition scheme, leading to an upcoming shareholder vote.
The Hub of Australian Finance News
Mayne Pharma (ASX:MYX) receives Supreme Court approval for Cosette Pharmaceuticals’ acquisition scheme, leading to an upcoming shareholder vote.
Mesoblast (ASX:MSB) secures 7-year FDA orphan-drug exclusivity for Ryoncil™ in treating pediatric SR-aGvHD, strengthening its IP protection.
WCM Global Growth Limited (ASX:WQG) declares a fully franked dividend of 1.89c per share for Q3 FY2025 and outlines a progressive dividend policy.
Orora Limited (ASX:ORA) announces strategic transformation and capital allocation plans, positioning for strong growth and shareholder returns.
Navigator Global Investments (ASX:NGI) upgrades FY25 earnings outlook, expecting Adjusted EBITDA to increase by 17-22%.
EDU Holdings (ASX:EDU) reports record FY24 revenue and profitability while proposing to delist from the ASX.
Treasury Wine Estates (ASX:TWE) appoints Sam Fischer as new CEO, succeeding Tim Ford after a 14-year tenure.
Errawarra Resources (ASX:ERW) reports multiple high-grade silver results up to 920g/t, highlighting significant exploration potential at Elizabeth Hill.
Brightstar Resources (ASX:BTR) begins its second ore processing campaign and advances the development of the Fish underground mine, aiming for increased gold production.
Bayan Mining and Minerals Ltd (ASX:BMM) confirms high-grade gold potential at Bayan Springs, Nevada, validating its Carlin-style mineralization model.